JPMorgan Chase & Co. lowered shares of CONVATEC Grp PL/ADR (OTCMKTS:CNVVY) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday, The Fly reports.
CNVVY has been the topic of several other research reports. Jefferies Financial Group assumed coverage on shares of CONVATEC Grp PL/ADR in a report on Wednesday, October 3rd. They issued a buy rating on the stock. Goldman Sachs Group cut shares of CONVATEC Grp PL/ADR from a buy rating to a neutral rating in a report on Tuesday.
Shares of OTCMKTS CNVVY opened at $7.99 on Tuesday. CONVATEC Grp PL/ADR has a 52 week low of $7.42 and a 52 week high of $12.61.
CONVATEC Grp PL/ADR Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Recommended Story: Find a Trading Strategy That Works
Receive News & Ratings for CONVATEC Grp PL/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONVATEC Grp PL/ADR and related companies with MarketBeat.com's FREE daily email newsletter.